For the PD‐L1 unequivocally strong positive and negative cell lines (Figure 1, B–D) and NSCLC tissue samples (Figure 1, E and H) no significant difference in outcome was observed between the approved assays and LDTs for the different PD‐L1 clones, nor between the different approved assays themselves (data not shown, P values ranging from 0.1 to 1.0). Here, CD274 is linked to non-small cell lung carcinoma.